NMN (Nicotinamide Mononucleotide)NMN (Nicotinamide Mononucleotide)
coenzyme
别名: Nicotinamide Mononucleotide, beta-NMN, NAD+ Precursor
About
NMN is a direct precursor to NAD+, a critical coenzyme for mitochondrial energy metabolism and sirtuin-mediated cellular repair. NAD+ levels decline approximately 50% between ages 40-60, correlating with cardiovascular aging. A 2024 RCT showed NMN at 250 mg/day improved arterial stiffness and reduced aortic pulse wave velocity in middle-aged adults.
How It Works
Direct precursor to NAD+ (nicotinamide adenine dinucleotide), a critical coenzyme for mitochondrial energy metabolism, sirtuin-mediated DNA repair, and PARP-mediated stress response; supports endothelial function by restoring SIRT1 activity in vascular smooth muscle; activates AMPK improving metabolic health markers associated with cardiovascular risk.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| Arterial Stiffness | C | 2 | 100 | 查看 → |
| Heart Failure | D | 0 | -- | 查看 → |
Side Effects
- Generally well-tolerated
- Mild gastrointestinal discomfort
- Flushing (rare)
- Headache (rare)
Drug & Supplement Interactions
- May interact with NAD+-dependent medications
- Theoretical interaction with diabetes medications (may affect glucose metabolism)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。